CDC recommends Pfizer's Covid-19 booster for ages 12 to 15 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
July 18, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JULY 18, 2025
CDC recommends Pfizer's Covid-19 booster for ages 12 to 15

USA

Reuters
06 January, 2022, 09:25 am
Last modified: 06 January, 2022, 09:30 am

Related News

  • US CDC vaccine presentation cites study that does not exist: author
  • Trump begins mass layoffs of 10,000 staffers at FDA, CDC, other US health agencies
  • US FDA approves Pfizer's drug for rare bleeding disorder
  • CDC issues health alert for bird flu infection in US
  • Pfizer cuts earnings outlook on lower Covid-19 drug sales

CDC recommends Pfizer's Covid-19 booster for ages 12 to 15

Data from Israel's Health Ministry presented at the meeting suggested that vaccinated children aged 12 to 15 who were five to six months past their second dose were being infected at the same rate as unvaccinated kids by the Omicron variant of the virus

Reuters
06 January, 2022, 09:25 am
Last modified: 06 January, 2022, 09:30 am
 Vials of the Pfizer-BioNTech coronavirus disease (Covid-19) pediatric vaccine are pictured in Lansdale, Pennsylvania, US, December 5, 2021. Photo :Reuters
Vials of the Pfizer-BioNTech coronavirus disease (Covid-19) pediatric vaccine are pictured in Lansdale, Pennsylvania, US, December 5, 2021. Photo :Reuters

The US Centers for Disease Control and Prevention (CDC) said on Wednesday it expanded the eligibility of Pfizer Inc and BioNTech SE's booster doses to those 12 to 15 years old.

The move came after a panel of outside experts advising the CDC voted earlier to recommend booster shots of the Covid-19 vaccine be made available for ages 12 to 15.

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 13 to 1 to recommend that the US health agency support booster shots for those aged 12 to 15 at least five months after their second dose.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The panel also said the CDC should strengthen its recommendation for boosters for ages 16 and 17. The agency had previously made the shots available to those teenagers, but had stopped short of suggesting that all of them should receive the additional jab.

The CDC said in a statement it now recommended that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer/BioNTech vaccination series.

Covid-19 cases in the United States have hit record levels in recent days due to the fast spreading Omicron variant of the virus. Infection rates are surging as many workers and school children return from holiday vacations, raising the prospect of overwhelmed health systems as well as closed businesses and schools.

"Covid is overwhelming our hospitals and our children's hospitals," said panel member Dr. Katherine Poehling, a professor at Wake Forest School of Medicine. "This is a tool we need to use, and help our children through this pandemic."

Data from Israel's Health Ministry presented at the meeting suggested that vaccinated children aged 12 to 15 who were five to six months past their second dose were being infected at the same rate as unvaccinated kids by the Omicron variant of the virus. After receiving a booster shot, the infection rate dropped sharply, according to the data.

Dr. Peter Marks, a top regulator at the US Food and Drug Administration, said that it is reasonable to extend the boosters down to 12- to 15-year-olds given the current surge in cases.

The FDA had authorized the additional doses US FDA authorizes Pfizer's Covid-19 booster for 12- to 15-year-olds for the age group on Monday, but the CDC sign-off was needed before the shots can be administered.

"This booster dose will provide optimized protection against Covid-19 and the Omicron variant," CDC Director Rochelle Walensky said in the statement.

Some scientists have expressed concerns about the booster shots due to rare cases of heart inflammation called myocarditis that have been linked to both the Pfizer/BioNTech and Moderna vaccines, particularly in young men.

While there is limited data on myocarditis after booster doses for ages 12 to 15, the FDA has said evidence from both the United States and Israel indicates that the risk of myocarditis in men aged 18-40 is significantly lower after booster shots than after the second vaccine dose.

Only two cases of myocarditis were reported in Israel among 44,000 adolescents aged 12 to 15 who received a third dose of the Pfizer/BioNTech vaccine, the Israeli Health Ministry said on Wednesday.

Coronavirus chronicle / Top News / World+Biz

CDC / Pfizer / booster

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Police fire teargas shells at the banned Awami League supporters during a clash in the Gopalganj district town on 16 July 2025. Photo: Collected
    75 named, 500 unidentified accused in Gopalganj unrest case, 45 arrested
  • Governments often rely on foreign loans. Russia’s loans covered 90% of the Rooppur Nuclear Power plant project's cost. Photo: Collected
    Loan tenure for Rooppur plant extended 
  • Chattogram-based Western Marine Shipyard Ltd has exported two tugboats—Ghaya and Khalid—to UAE-based Marwan Shipping Ltd, earning $1.6 million. The vessels were officially handed over at the Chittagong Boat Club on 17 July. Photo: Courtesy
    Refined sugar imports double in FY25 as duty cuts bite local refiners

MOST VIEWED

  • Bangladesh Bank buys $313m more in second dollar auction in three days
    Bangladesh Bank buys $313m more in second dollar auction in three days
  • Representational image. File Photo: Syed Zakir Hossain/TBS
    Malaysia grants Bangladeshi workers multiple-entry visas
  • The Chattogram Custom House building in Chattogram. File Photo: Collected
    Software slowdown disrupts customs operations nationwide
  • NCP leaders are seen getting on an armoured personnel carrier (APC) of the army to leave Gopalganj following attacks on their convoy after the party's rally in the district today (16 july). Photo: Focus Bangla
    NCP leaders leave Gopalganj in army's APC following attack on convoy, clashes between AL, police
  • Renata’s manufacturing standards win european recognition
    Renata’s manufacturing standards win european recognition
  • The supporters of local Awami League and Chhatra League locked in a clash with police following attacks on NCP convoy this afternoon (16 July). Photo: Collected
    Gopalganj under curfew; 4 killed as banned AL, police clash after attack on NCP leaders

Related News

  • US CDC vaccine presentation cites study that does not exist: author
  • Trump begins mass layoffs of 10,000 staffers at FDA, CDC, other US health agencies
  • US FDA approves Pfizer's drug for rare bleeding disorder
  • CDC issues health alert for bird flu infection in US
  • Pfizer cuts earnings outlook on lower Covid-19 drug sales

Features

Illustration: TBS

20 years of war, 7.5m tonnes of bombs, 1.3m dead: How the US razed Vietnam to the ground

12h | The Big Picture
On 17 July 2024, Dhaka University campus became a warzone with police firing tear shells and rubber bullets to control the student movement. File Photo: Rajib Dhar/TBS

17 July 2024: Students oust Chhatra League from campuses, Hasina promises 'justice' after deadly crackdown

19h | Panorama
Abu Sayeed spread his hands as police fired rubber bullets, leading to his tragic death. Photos: Collected

How Abu Sayed’s wings of freedom ignited the fire of July uprising

2d | Panorama
Illustration: TBS

Open source legal advice: How Facebook groups are empowering victims of land disputes

3d | Panorama

More Videos from TBS

Why the conflicting claims over Gopalganj autopsies?

Why the conflicting claims over Gopalganj autopsies?

13h | TBS Stories
Gopalganj violence in international media

Gopalganj violence in international media

13h | TBS World
The Philippines has become a laboratory for China's disinformation propaganda

The Philippines has become a laboratory for China's disinformation propaganda

14h | TBS World
Gopalganj clash: Army urges not to be misled by rumors

Gopalganj clash: Army urges not to be misled by rumors

15h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net